Robert I. Goldfarb, Esq.
.png/:/cr=t:5.36%25,l:5.36%25,w:89.29%25,h:89.29%25/rs=w:400,cg:true,m)
Mr. Goldfarb has over 35 years of legal experience and over 20 years of experience in the pharmaceutical industry. He was President and General Counsel of Accubreak Pharmaceuticals Inc from 2007 until recently when he began his own practice. From September 2005 until December 2006, Mr. Goldfarb was Senior President, General Counsel and Secretary of Andrx Corporation. In December 2006, Mr. Goldfarb represented Andrx in connection with the $1.9 billion merger with Watson Pharmaceuticals, Inc., including negotiating the merger agreement and ancillary documents as well as negotiations with the FTC and SEC. Mr. Goldfarb joined Andrx in March 2000, became Assistant General Counsel and in 2003 was appointed Vice President. Prior to joining Andrx, Mr. Goldfarb was a partner with the national law firm Hughes, Hubbard & Reed. He represented a number of corporate and financial institutions with respect to corporate mergers, acquisitions and divestitures as well as real estate acquisitions, sales and financings and corporate litigation. Mr. Goldfarb has been and is currently a board member for number of a privately held pharmaceutical companies located in New York and Florida. Mr. Goldfarb obtained his bachelor’s degree from the University of Connecticut and his J.D. from the University of Florida. He is a member of the Florida Bar.